BPG is committed to discovery and dissemination of knowledge
- Number of total visits
-
2814484
- Number of visits today
- 287
- Number of downloads
-
2064808
MEMBERSHIP
Cited by in F6Publishing
Number |
Citing Articles |
1 |
Jiang Z, Dai C. Potential Treatment Strategies for Hepatocellular Carcinoma Cell Sensitization to Sorafenib. J Hepatocell Carcinoma 2023;10:257-66. [PMID: 36815094 DOI: 10.2147/JHC.S396231] [Reference Citation Analysis]
|
2 |
Dai Y, Jiang H, Jiang H, Zhao S, Zeng X, Sun R, Zheng R. Optimal timing of combining sorafenib with trans-arterial chemoembolization in patients with hepatocellular carcinoma: A meta-analysis. Transl Oncol 2021;14:101238. [PMID: 34628285 DOI: 10.1016/j.tranon.2021.101238] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
|
3 |
Chen X, Zhu F, Wang B, Zhou Y, Xiong H, Fan T, Ke W. Clinical Effect of Iodine-125 Seed Implantation in Patients with Primary Liver Cancer and Its Effect on Th1/Th2 Cells in Peripheral Blood. J Oncol 2021;2021:6199732. [PMID: 34367285 DOI: 10.1155/2021/6199732] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345